Biodesix Statistics
NASDAQ: BDSXHealth CareMedical SpecialitiesUSD
7.56-0.74 (-8.92%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Biodesix by the numbers
Biodesix has a market capitalization of $83.8 million based on 11.09M shares outstanding. With trailing EPS of $-2.69, Biodesix is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 65.8% below its 50-day average and 59.9% below its 200-day average.
Average daily trading volume is 164.58K shares, or about $1.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BDSX valuation vs. peer median
| Metric | BDSX | Peer median | Difference |
|---|---|---|---|
| Market cap | $83.83M | $82.04M | +2% |
| Avg. volume | 164.58K | 35.62K | +362% |
Peer median across 8 companies: XGN, SERA, KEQU, BNR, TLSI, MDXH, AMS, ACON.
Valuation
- Market cap
- $83.83M
- Price / sales (latest FY)
- 0.95
- EPS (TTM)
- $-2.69
- Shares outstanding
- 11.09M
Price and trading
- Previous close
- 8.30
- Open
- 8.17
- Day range
- 7.50 – 8.45
- 52-week range
- 5.26 – 31.97
- 52-week change
- +10.69%
- Beta
- —
- Volume
- 205.37K
- Average volume
- 164.58K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 83.83M
- Forward Pe
- -34.36
- Eps
- -2.69
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 31.97
- Week52 Low
- 5.26
- Avg Volume
- 164.58K
- Shares Outstanding
- 11.09M
- Ma50
- 22.08
- Ma200
- 18.84
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -76.35%
- Pct From52w Low
- 43.73%